Heartworm disease causes prolonged cardiovascular suffering in affected dogs and is entirely preventable, yet prevention gaps create an ongoing welfare burden that falls disproportionately on dogs in lower-income households.
Heartworm disease welfare impact is substantially determined by whether the condition is prevented or treated. Prevention — a monthly tablet or topical applied consistently — produces essentially zero welfare cost for the dog. Treatment of established disease involves months of exercise restriction that causes behavioral frustration in active dogs, the physical discomfort of adulticide injections, and the risk of serious complications from dying worms causing pulmonary embolism. Dogs with advanced heartworm disease experience progressive breathlessness, exercise intolerance, and potentially fatal cardiac complications over months to years — a prolonged welfare deterioration that is entirely avoidable. The prevention equity gap — where lower-income dog owners face cost barriers to consistent prevention that higher-income owners do not — creates a welfare disparity that maps onto socioeconomic status. Subsidized prevention programs and free clinic distribution of preventives address both individual dog welfare and population-level prevention in high-incidence areas.